Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Resverlogix Corp
RVXCF
Primary Symbol:
T.RVX
Healthcare
Biotechnology
Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the...
treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:RVX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(27)
•••
Jkj193741
X
View Profile
View Bullboard History
Comment by
Jkj193741
on Nov 20, 2022 11:45am
RE:Mccaffrey Awards himself
SAD!
(27)
•••
Jkj193741
X
View Profile
View Bullboard History
Post by
Jkj193741
on Nov 20, 2022 11:41am
The 50 day
Resverlogix (TSE:RVX) Stock Crosses Above 50-Day Moving Average of $0.19 Posted by MarketBeat News on Nov 19th, 2022 Share on Twitter Share on Facebook Share on LinkedIn Share on Stocktwits
...more
Discover Options Trading Strategies to Minimize your Tax Burden
posted Nov 30, 2024 9:00am by
Bank of Montreal
-
|
Options trading doesn’t come without tax implications, but there are ways investors can still optimize their after-tax returns with just a little bit of understanding. Approaches for investors to keep in mind are holding periods, wash-sales rule, tax advantaged accounts, and qualified cover calls. BMO’s enhanced InvestorLine platform. Industry-leading tools and capabilities specifically designed to empower options traders. ...read more
(19)
•••
fuzzyjr
X
View Profile
View Bullboard History
Comment by
fuzzyjr
on Nov 18, 2022 12:03pm
RE:RE:Mccaffrey Awards himself
ya u probably won't get much argument. Think a lot of Sh 's would be happy with a Buck or 2 & run hard. I believe it's worth much more but this management team/ceo have
...more
(17)
•••
general360
X
View Profile
View Bullboard History
Comment by
general360
on Nov 18, 2022 11:15am
RE:Mccaffrey Awards himself
the optics are fantastic on this. we're being told how much time this is taking, management is in TALKS, just keep WAITING, thanks for your PATIENCE. BAM! more dilution from mcrappity, and
...more
(3)
•••
seanj1
X
View Profile
View Bullboard History
Post by
seanj1
on Nov 17, 2022 9:48pm
Mccaffrey Awards himself
Gives himslf 500K in rights for job well done !? Resverlogix top management and board members have been the only winners in this company,, steady jobs with lofty salaries,etc for past 20+ years.
...more
(16)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Oct 19, 2022 8:27am
RE:Long COVID
hummmmmm,,,the only thing that makes sense is that RVX is in wait for ZEN data to be laid out where one of those partnering entites takes the whole sad affair out for a pittance..maybe two of them
...more
(17)
•••
general360
X
View Profile
View Bullboard History
Post by
general360
on Oct 18, 2022 12:20pm
Long COVID
Addiction drug shows promise lifting long COVID brain fog, fatigue https://www.yahoo.com/news/addiction-drug-shows-promise-lifting-101204918.html let's wait another YEAR before we start our on
...more
(16)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Oct 13, 2022 9:26am
RE:congrats management
,,,aaacchhhh,,the Market will always handsomely reward a company which exhibits incompetence with a severe thrashing,,,,it is thoroughly caning DMcC and the shareholders in public for his failures
...more
(19)
•••
fuzzyjr
X
View Profile
View Bullboard History
Comment by
fuzzyjr
on Oct 12, 2022 4:04pm
RE:congrats management
He's useless, rumour mill has it that even close friends are calling em a bag a s h I. T now. Be nice to se em get a tune up at the zen agm - little puke prob won't show being the
...more
(18)
•••
maoae7
X
View Profile
View Bullboard History
Comment by
maoae7
on Oct 11, 2022 9:58pm
RE:congrats management
I remember a bunch of doctors pumping this stock from $5.all the way to $25. In just a few weeks. I was ready the buy at $5. but i missed the boat. I am not a stock chaser. I bought some years later
...more
(17)
•••
general360
X
View Profile
View Bullboard History
Post by
general360
on Oct 11, 2022 2:29pm
congrats management
i'm down 94% and counting, including 10% today. thats good work right there. RSU's for everyone! freebies for all! for what? FOR THE GREAT WORK YOU"VE DONE! KUDOS ALL
...more
(16)
•••
narmac
X
View Profile
View Bullboard History
Post by
narmac
on Sep 28, 2022 8:00am
Phase lll Covid Trial?
aacchhhhh,,,another year, and most likely longer, of nothingness coming.....this company is incredibly backward when it comes to urgency. Inept and complacent with shareholders. At least Sweeny is
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 28, 2022 7:12am
New Press Release - Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions
CALGARY, Alberta, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the “Company”) (TSX:RVX) today announced that apabetalone’s future clinical development related to COVID-19 will focus on the prevention and treatment of Post COVID-19 Conditions (PCC), colloquially known as...
read article.
(99)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Sep 19, 2022 9:03am
RE:I suspect No Covid Trial
The focus needs to be on the bigger picture. BOM2 !!! jmo G1945V
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >